Similar articles for PMID: 19446187

Year	Number of Results
1987	1
1988	1
1990	1
1992	2
1993	3
1994	2
1995	6
1996	1
1997	2
1998	5
1999	1
2000	2
2001	5
2002	6
2003	3
2004	12
2005	22
2006	41
2007	39
2008	46
2009	71
2010	10
2011	10
2012	9
2013	8
2014	9
2015	11
2016	2
2017	4
2018	2
2019	7
2020	6
2021	1
2024	0

1

Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.

Gómez CE, Nájera JL, Sánchez R, Jiménez V, Esteban M. Gómez CE, et al. Vaccine. 2009 May 21;27(24):3165-74. doi: 10.1016/j.vaccine.2009.03.049. Epub 2009 Apr 8. Vaccine. 2009. PMID: 19446187

2

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

Gómez CE, Nájera JL, Jiménez EP, Jiménez V, Wagner R, Graf M, Frachette MJ, Liljeström P, Pantaleo G, Esteban M. Gómez CE, et al. Vaccine. 2007 Apr 12;25(15):2863-85. doi: 10.1016/j.vaccine.2006.09.090. Epub 2006 Oct 16. Vaccine. 2007. PMID: 17113200

3

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.

Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M. Abaitua F, et al. Virus Res. 2006 Mar;116(1-2):11-20. doi: 10.1016/j.virusres.2005.08.008. Epub 2005 Oct 7. Virus Res. 2006. PMID: 16214252

4

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.

Gómez CE, Nájera JL, Jiménez V, Bieler K, Wild J, Kostic L, Heidari S, Chen M, Frachette MJ, Pantaleo G, Wolf H, Liljeström P, Wagner R, Esteban M. Gómez CE, et al. Vaccine. 2007 Mar 1;25(11):1969-92. doi: 10.1016/j.vaccine.2006.11.051. Epub 2006 Dec 6. Vaccine. 2007. PMID: 17224219

5

Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.

Gómez CE, Abaitua F, Rodríguez D, Esteban M. Gómez CE, et al. Virus Res. 2004 Sep 15;105(1):11-22. doi: 10.1016/j.virusres.2004.04.008. Virus Res. 2004. PMID: 15325077

6

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.

Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y. Yu S, et al. Vaccine. 2008 Nov 11;26(48):6124-31. doi: 10.1016/j.vaccine.2008.09.017. Epub 2008 Sep 22. Vaccine. 2008. PMID: 18812199

7

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.

García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G, Foulds KE, McDermott A, Kao SF, Roederer M, Hawkins N, Self S, Yao J, Farrell P, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo A, Weiss D, Lee C, Kibler K, Jacobs B, Asbach B, Wagner R, Ding S, Pantaleo G, Esteban M. García-Arriaza J, et al. J Virol. 2015 Aug;89(16):8525-39. doi: 10.1128/JVI.01265-15. Epub 2015 Jun 3. J Virol. 2015. PMID: 26041302 Free PMC article.

8

Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.

Didierlaurent A, Ramirez JC, Gherardi M, Zimmerli SC, Graf M, Orbea HA, Pantaleo G, Wagner R, Esteban M, Kraehenbuhl JP, Sirard JC. Didierlaurent A, et al. Vaccine. 2004 Sep 3;22(25-26):3395-403. doi: 10.1016/j.vaccine.2004.02.025. Vaccine. 2004. PMID: 15308364

9

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.

García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Lee C, Kibler KV, Jacobs BL, Wagner R, Ding S, Pantaleo G, Esteban M. García-Arriaza J, et al. J Virol. 2017 Apr 13;91(9):e02182-16. doi: 10.1128/JVI.02182-16. Print 2017 May 1. J Virol. 2017. PMID: 28179536 Free PMC article.

10

DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.

Rasmussen RA, Ong H, Kittel C, Ruprecht CR, Ferrantelli F, Hu SL, Polacino P, McKenna J, Moon J, Travis B, Ruprecht RM. Rasmussen RA, et al. Vaccine. 2006 Mar 20;24(13):2324-32. doi: 10.1016/j.vaccine.2005.11.063. Epub 2005 Dec 19. Vaccine. 2006. PMID: 16406147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

315 results

Results by year